We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00895180
Brief Title: Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

First Submitted : May 7, 2009
First Submitted that Met QC Criteria : May 7, 2009
First Posted : May 8, 2009 (Estimate)

Results First Submitted : November 18, 2016
Results First Submitted that Met QC Criteria : February 13, 2017
Results First Posted : March 29, 2017

Last Update Submitted that Met QC Criteria : November 30, 2017
Last Update Posted : December 27, 2017